Immunic, Inc. Reports Third Quarter 2021 Financial Results and Highlights Recent Activity

Go back to Immunic, Inc. Reports Third Quarter 2021 Financial Results and Highlights Recent Activity

Immunic Inc. (IMUX) Reports Q3 EPS of ($0.76), Cash and Cash Equivalents of $110.4M

November 4, 2021 6:45 AM EDT

Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.76).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

... More